SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-126185
Filing Date
2017-04-17
Accepted
2017-04-17 17:16:57
Documents
1
Group Members
AL SCHWENCKBILL REINHARDCALVIN WALLEN IIICHARLES LITTLEJOHNHUGH G. NOLANJAMES D. WATSONJAMES F BOYLE JR CREDIT SHELTER TRUSTJEAN STACKJEFFREY A. MORRISJOHN G. GAZONASMARC KELLEYMARTA SCHWENCKPETER R. CULPEPPERROBERT TAUROSASCOTT WEBBERSTEVE SMITHTIMES 11,

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d356199dsc13da.htm SC 13D/A 291926
  Complete submission text file 0001193125-17-126185.txt   293932
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Subject) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-32172 | Film No.: 17765299
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
MILLER COURTLANDT G (Filed by) CIK: 0000901585 (see all company filings)

Type: SC 13D/A